![](/img/cover-not-exists.png)
Longâterm results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with highâdose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma
Massaro, Fulvio, Stepanishyna, Yana, Manni, Martina, Luminari, Stefano, Galimberti, Sara, Marcheselli, Luigi, Visco, Carlo, Tecchio, Cristina, Stelitano, Caterina, Angrilli, Francesco, Petrini, Mario,Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16714
Date:
May, 2020
File:
PDF, 140 KB
2020